Document ID: chunk:federal_register_of_legislation:F2025C00183:clause:1_73296
Version: federal_register_of_legislation:F2025C00183
Segment Type: clause
Provision Reference: sch 1 cl 73296
Character Range: 272343–273586

73296              Characterisation of germline gene variants, including copy number variation where appropriate, requested by a specialist or consultant physician:                                                                                                                                                                                                                                                                                                                                                                                                                    1,200.00
                   (a) in genes associated with breast, ovarian, fallopian tube or primary peritoneal cancer, which must include at least:
                   (i) BRCA1 and BRCA2 genes; and
                   (ii) one or more other relevant genes; and
                   (b) in a patient:
                   (i) with breast, ovarian, fallopian tube or primary peritoneal cancer; and
                   (ii) for whom clinical and family history criteria place the patient at greater than 10% risk of having a pathogenic or likely pathogenic gene associated with breast, ovarian, fallopian tube or primary peritoneal cancer
                   Once per cancer diagnosis